Sequelae of Developmental Dysplasia of the Hip
Structural and Functional Sequelae of Developmental Dysplasia of the Hip
1 other identifier
observational
340
1 country
1
Brief Summary
The aim of this study is to assess long term effects of developmental dysplasia of the hip (DDH) to overall health and quality of life later in life. We compare hip radiographs, hip symptoms, clinical examination, head asymmetry, dental examination and intraoral scans of 170 children and young adults treated for DDH in their childhood with age and sex matched controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2015
CompletedFirst Posted
Study publicly available on registry
May 1, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedNovember 29, 2023
November 1, 2023
6.9 years
April 20, 2015
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wibergs Centre-Edge Angle
angle degree
10 - 30 years after DDH has been treated
Secondary Outcomes (4)
The Copenhagen Hip and Groin Outcome Score (HAGOS)
10 - 30 years after DDH has been treated
Oral Heath Impact Profile
10 - 30 years after DDH has been treated
Occlusal asymmetries
10 - 30 years after DDH has been treated
Presence of facial asymmetry
10 - 30 years after DDH has been treated
Other Outcomes (2)
Hip deformity
10 - 30 years after DDH has been treated
Asymmetry in clinical hip examination
10 - 30 years after DDH has been treated
Study Arms (2)
Treated for DDH in childhood
Subjects have had DDH in childhood. DDH has been diagnosed before age of 1,5 years and treated for.
Control
Age an sex matched controls of DDH patients
Eligibility Criteria
10-30 years old patientstreated for DDH in early childhood in Oulu University Hospital
You may qualify if:
- DDH has been diagnosed by clinical examination, ultrasound examination or by radiological examination and treatment begun before age of 1,5 years.
- Treated in Oulu University Hospital
You may not qualify if:
- neurological or developmental condition which can influence hip development such as cerebral palsy or spina bifida
- other significant congenital anomalies of musculoskeletal system such as club feet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oulu; Oulu University Hospital
Oulu, 90100, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juhana Leppilahti, Professor
University of Oulu
- STUDY DIRECTOR
Marita Valkama, Ph.D., M.D
University of Oulu, Oulu University Hospital, MRC Oulu
- STUDY DIRECTOR
Virpi Harila, Ph.D.
University of Oulu, MRC Oulu
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2015
First Posted
May 1, 2015
Study Start
January 1, 2016
Primary Completion
December 1, 2022
Study Completion (Estimated)
December 1, 2026
Last Updated
November 29, 2023
Record last verified: 2023-11